United States
3-Amino-1H-pyrazolo[3,4-b]quinoxaline
Inhibitor of CDK and GSK
| ALX-270-387-M001 | 1 mg | 47.00 USD |  |
||
| ALX-270-387-M005 | 5 mg | 155.00 USD | |
||
Selective inhibitor of CDK1/cyclin B (IC50=600nM), CDK5/p25 (IC50=400nM) and GSK-3β (IC50=1µM). Does not inhibit Cdc25 phosphatase activity (IC50>10µM).
Product Specification
| Formula: | C9H7N5 |
| MW: | 185.2 |
| Purity: | ≥98% (HPLC) |
| Appearance: | Red solid. |
| CAS: | 40254-90-8 |
| Solubility: | Soluble in DMSO. |
| Long Term Storage: | +4°C |
| Handling: | Packaged under inert gas. Protect from light. |
Please mouse over
Product Literature References
Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors: M.A. Ortega, et al.; Bioorg. Med. Chem. 10, 2177 (2002), Abstract;
Product Toolbox
PRODUCT RESOURCES
Datasheet
MSDS
RELATED PRODUCTS
By catalog section:
By biological activity:
CDK InhibitorGSK Inhibitor
PRODUCT SUPPORT
Technical ServiceBulk Quantity Quote
Customer Service
Related Literature
Scientific Posters
Disease-Associated Stress Signaling
Add to order list
 |
20-Sep-10 |
| Download as PDF | |
Catalogs
Diabetes Catalog
Add to order list
 |
14-Jun-10 |
| Download as PDF | |
